Chin Mark 4
4 · Harpoon Therapeutics, Inc. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
Chin Mark
Director10% Owner
Transactions
- Award
Common Stock
2024-01-01+1,072→ 12,801 total
Footnotes (1)
- [F1]Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). The fully vested RSUs were granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $12,500.